Per Wändell1, Axel C Carlsson2, Gunnar Ljunggren3. 1. Division of Family Medicine, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden; Academic Primary Healthcare Centre, Stockholm County Council, Huddinge, Sweden. Electronic address: per.wandell@ki.se. 2. Division of Family Medicine, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden; Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden. 3. Public Healthcare Services Committee Administration, Stockholm County Council, Box 6909, SE-102 39 Stockholm, Sweden; Medical Management Centre, Department of Learning, Informatics, Management and Ethics, Karolinska Institutet, Berzelius väg 3, SE-17177 Stockholm, Sweden.
Abstract
OBJECTIVE: Study of prevalence of gout with concomitant diseases. METHODS: Study population included all living persons in Stockholm County, Sweden, on January 1st 2013 (N=2,124,959). A diagnosis of gout was identified during 2013-2014, with information of diabetes mellitus and insulin resistance, hypertension, chronic heart failure, chronic kidney disease, alcohol abuse, and malignancies. Age-adjusted odds ratios (ORs) with 95% confidence intervals (95% CI) for women and men with gout, using individuals without gout as referents, were calculated. RESULTS: Age-adjusted odds of co-morbidities among individuals with gout vs. those without gout were: diabetes mellitus and insulin resistance 3.97 (95% CI 3.65-4.31) in women and 1.88 (95% CI 1.78-1.99) in men; hypertension 4.02 (95% CI 3.69-4.37) in women and 3.21 (95% CI 3.06-3.37) in men; chronic heart failure 4.72 (95% CI 4.31-5.19) in women and 2.84 (95% CI 2.66-3.04) in men; chronic kidney disease 2.08 (95% CI 1.50-2.87) in women and 2.39 (95% CI 2.15-2.66) in men; alcohol abuse 8.98 (95% CI 8.15-9.80) in women and 4.38 (95% CI 4.10-4.69) in men; and malignancies 1.32 (95% CI 1.17-1.48) in women and 1.13 (95% CI 1.06-1.21) men. CONCLUSION: Gout is a warning sign for concomitant diseases, e.g. alcoholism, diabetes, cardiovascular diseases, and cancer. KEY MESSAGES.
OBJECTIVE: Study of prevalence of gout with concomitant diseases. METHODS: Study population included all living persons in Stockholm County, Sweden, on January 1st 2013 (N=2,124,959). A diagnosis of gout was identified during 2013-2014, with information of diabetes mellitus and insulin resistance, hypertension, chronic heart failure, chronic kidney disease, alcohol abuse, and malignancies. Age-adjusted odds ratios (ORs) with 95% confidence intervals (95% CI) for women and men with gout, using individuals without gout as referents, were calculated. RESULTS: Age-adjusted odds of co-morbidities among individuals with gout vs. those without gout were: diabetes mellitus and insulin resistance 3.97 (95% CI 3.65-4.31) in women and 1.88 (95% CI 1.78-1.99) in men; hypertension 4.02 (95% CI 3.69-4.37) in women and 3.21 (95% CI 3.06-3.37) in men; chronic heart failure 4.72 (95% CI 4.31-5.19) in women and 2.84 (95% CI 2.66-3.04) in men; chronic kidney disease 2.08 (95% CI 1.50-2.87) in women and 2.39 (95% CI 2.15-2.66) in men; alcohol abuse 8.98 (95% CI 8.15-9.80) in women and 4.38 (95% CI 4.10-4.69) in men; and malignancies 1.32 (95% CI 1.17-1.48) in women and 1.13 (95% CI 1.06-1.21) men. CONCLUSION:Gout is a warning sign for concomitant diseases, e.g. alcoholism, diabetes, cardiovascular diseases, and cancer. KEY MESSAGES.
Authors: Mats Dehlin; Panagiota Drivelegka; Valgerdur Sigurdardottir; Anna Svärd; Lennart T H Jacobsson Journal: Arthritis Res Ther Date: 2016-07-13 Impact factor: 5.156
Authors: Richard O Day; Lauren J Frensham; Amy D Nguyen; Melissa T Baysari; Eindra Aung; Annie Y S Lau; Nicholas Zwar; Jennifer Reath; Tracey Laba; Ling Li; Andrew McLachlan; William B Runciman; Rachelle Buchbinder; Robyn Clay-Williams; Enrico Coiera; Jeffrey Braithwaite; H Patrick McNeil; David J Hunter; Kevin D Pile; Ian Portek; Kenneth Mapson WIlliams; Johanna I Westbrook Journal: BMJ Open Date: 2017-10-16 Impact factor: 2.692
Authors: Per Wändell; Axel C Carlsson; Xinjun Li; Danijela Gasevic; Johan Ärnlöv; Martin J Holzmann; Jan Sundquist; Kristina Sundquist Journal: Clin Rheumatol Date: 2017-01-13 Impact factor: 2.980
Authors: Meliha C Kapetanovic; Peter Nilsson; Carl Turesson; Martin Englund; Nicola Dalbeth; Lennart Jacobsson Journal: Arthritis Res Ther Date: 2018-08-29 Impact factor: 5.156
Authors: Tahzeeb Fatima; Peter M Nilsson; Carl Turesson; Mats Dehlin; Nicola Dalbeth; Lennart T H Jacobsson; Meliha C Kapetanovic Journal: Arthritis Res Ther Date: 2020-10-16 Impact factor: 5.156
Authors: Sandy ElSayed; Gregory D Jay; Ralph Cabezas; Marwa Qadri; Tannin A Schmidt; Khaled A Elsaid Journal: Front Immunol Date: 2021-12-21 Impact factor: 7.561
Authors: Meliha C Kapetanovic; Mohaned Hameed; Aleksandra Turkiewicz; Tuhina Neogi; Tore Saxne; Lennart Jacobsson; Martin Englund Journal: RMD Open Date: 2016-11-01